RPM Improves Hypertension Outcomes but Drives Up Costs

RPM Improves Hypertension Outcomes but Drives Up Costs

Remote Patient Monitoring (RPM) benefits hypertensive patients by boosting medication adherence and slashing hospital visits. A study revealed a 3.3% rise in medication fills and reduced emergencies, yet incurred a $274 hike per patient. RPM’s quick impact surprised researchers, lowering hospitalizations but elevating outpatient visits, driving up costs. Targeted patient selection and limited use could optimize hypertension-focused RPM. Additional studies demonstrate RPM’s efficacy in managing hypertension, showcasing lowered blood pressure figures. Despite its proven clinical advantages, the surge in RPM claims, particularly in hypertension cases, highlights its growing but cost-intensive role in healthcare. RPM’s evolution signifies improved outcomes but prompts crucial cost-effectiveness considerations for long-term integration.

Medigy Insights

Remote Patient Monitoring (RPM) exhibits a 3.3% medication fill increase, fewer emergencies, yet a $274 rise in patient costs. Surprisingly swift, RPM reduced hospitalizations but raised outpatient visits, escalating expenses. Tailored patient selection and constrained use could enhance hypertension-focused RPM. Additional studies affirm its efficacy, notably in reducing blood pressure. However, the surge in RPM claims, especially in hypertension, emphasizes its burgeoning yet cost-heavy healthcare role. RPM's advancement underscores improved outcomes, urging vital cost-effective integration contemplation.


Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Apr 26, 2024 at 6:14am